Noval-K2 – Protecting Performance from Within
Vitamin K2 is an essential fat-soluble vitamin that plays a key role in supporting bone health and cardiovascular wellness by helping direct calcium to the bones and away from soft tissues. However, conventional Vitamin K2 formulations may exhibit limited stability and inconsistent absorption.
Noval K2 is developed using advanced microencapsulation technology, which protects Vitamin K2 within a specialized matrix to enhance its stability and improve handling characteristics. This approach helps maintain the integrity of the active compound and supports better formulation performance.
Microencapsulated Vitamin K2 offers a stable and reliable solution for nutraceutical formulations, supporting optimal performance and broader application potential.
Experience the advantages of advanced liposomal curcumin technology designed to support better absorption, stability, and overall formulation performance.
Suitable for a wide range of nutraceutical and functional health formulations across multiple dosage formats.
Ideal for convenient daily nutraceutical supplementation.
Suitable for stable and easy-to-consume health formulations.
Designed for quick-mix and on-the-go nutritional applications.
Suitable for liquid formulations with enhanced ingredient delivery.
Ideal for precise and convenient liquid nutraceutical delivery.
Designed for versatile blending and convenient nutritional use.
Designed for enhanced ingredient delivery in an easy-to-swallow format.
© 2026 OzaBio | All Rights Reserved.
Dynamic Light Scattering (DLS) is employed to evaluate the particle size distribution and polydispersity of liposomal formulations, providing essential information on colloidal stability, dispersion uniformity, and potential bioavailability.
For example – Lipoza®-Curcumin
Caco-2 studies utilize human intestinal epithelial cell monolayers to evaluate the permeability and predicted absorption of test substances across the gut barrier.
For example – Lipoza-Glutathione
Demonstrated superior permeability, showing 0.95% transport compared to 0.29% for Reduced L-Glutathione—an approximate 3.28-fold increase. This enhanced permeability, despite lower glutathione content, indicates improved intestinal absorption and supports its potential as a more bioavailable form of glutathione supplementation.
Fill out the form below and we'll get back to you soon
* indicates required question